MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis

Atherosclerosis

Volumn 232, Issue 1, 2014, Pages 171-179

  Gao, Song ^a,b   Wassler, Michael ^b   Zhang, Lulu ^b   Li, Yangxin ^a   Wang, Jun ^a   Zhang, Yi ^a,c   Shelat, Harnath ^b   Williams, Jason ^b   Geng, Yong Jian ^a,b  

^a TEXAS HEART INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Artery; Atherosclerosis; Insulin like growth factor; MicroRNA; Smooth muscle cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; APOLIPOPROTEIN E; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 133A; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION; RNA STABILITY; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ARTERY; ATHEROSCLEROSIS; INSULIN-LIKE GROWTH FACTOR; MICRORNA; SMOOTH MUSCLE CELL;

3' UNTRANSLATED REGIONS; ANIMALS; ATHEROSCLEROSIS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTOR, IGF TYPE 1; RNA, MESSENGER;

EID: 84891602284     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.11.029     Document Type: Article

References (30)

1. Geng Y.J., Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002 Sep 1, 22(9):1370-1380.
2. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011 May 19, 473(7347):317-325.
3. Geng Y.J. Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis. Curr Atheroscler Rep 2001 May, 3(3):234-242.
4. Dzau V.J., Braun-Dullaeus R.C., Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 2002 Nov, 8(11):1249-1256.
5. Engberding N., San Martin A., Martin-Garrido A., et al. Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2009 Mar, 29(3):408-415.
6. Conti E., Musumeci M.B., De Giusti M., et al. IGF-1 and atherothrombosis: relevance to pathophysiology and therapy. Clin Sci (Lond) 2011 May, 120(9):377-402.
7. Crea F., Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend, or foeα. Eur Heart J 2005 Oct, 26(20):2075-2076.
8. Lim H.J., Park H.Y., Ko Y.G., et al. Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis. Biochem Biophys Res Commun 2004 Dec 17, 325(3):1106-1114.
9. -/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability. Arterioscler Thromb Vasc Biol 2010 Oct, 30(10):1916-1924.
10. von der Thusen J.H., Borensztajn K.S., Moimas S., et al. IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype. Am J Pathol 2011 Feb, 178(2):924-934.
11. Juul A., Scheike T., Davidsen M., Gyllenborg J., Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002 Aug 20, 106(8):939-944.
12. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 Jan 23, 116(2):281-297.
13. Huang M.B., Xu H., Xie S.J., Zhou H., Qu L.H. Insulin-like growth Factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis. PLoS One 2011, 6(12):e29173.
14. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007 Dec 21, 318(5858):1931-1934.
15. Li Y., Song Y.H., Li F., Yang T., Lu Y.W., Geng Y.J. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem Biophys Res Commun 2009 Mar 27, 381(1):81-83.
16. Zhang C. MicroRNAs: role in cardiovascular biology and disease. Clin Sci (Lond) 2008 Jun, 114(12):699-706.
17. Chen J.F., Mandel E.M., Thomson J.M., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006 Feb, 38(2):228-233.
18. Takaya T., Ono K., Kawamura T., et al. MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ J 2009 Aug, 73(8):1492-1497.
19. Hua Y., Zhang Y., Ren J. IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a. JCell Mol Med 2012 Jan, 16(1):83-95.
20. Torella D., Iaconetti C., Catalucci D., et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch invitro and vascular remodeling invivo. Circ Res 2011 Sep 30, 109(8):880-893.
21. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C. Anecessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009 Feb 27, 104(4):476-487.
22. Cordes K.R., Sheehy N.T., White M.P., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009 Aug 6, 460(7256):705-710.
23. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011 Jan 20, 469(7330):336-342.
24. Cheng J., Du J. Mechanical stretch simulates proliferation of venous smooth muscle cells through activation of the insulin-like growth factor-1 receptor. Arterioscler Thromb Vasc Biol 2007 Aug, 27(8):1744-1751.
25. Higashi Y., Sukhanov S., Parthasarathy S., Delafontaine P. The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptor. Am J Physiol Heart Circ Physiol 2008 Oct, 295(4):H1684-H1689.
26. Scheidegger K.J., Du J., Delafontaine P. Distinct and common pathways in the regulation of insulin-like growth factor-1 receptor gene expression by angiotensin II and basic fibroblast growth factor. JBiol Chem 1999 Feb 5, 274(6):3522-3530.
27. Jia G., Mitra A.K., Gangahar D.M., Agrawal D.K. Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein. Exp Mol Pathol 2010 Aug, 89(1):20-26.
28. Scheidegger K.J., James R.W., Delafontaine P. Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. JBiol Chem 2000 Sep 1, 275(35):26864-26869.
29. Xin M., Small E.M., Sutherland L.B., et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 2009 Sep 15, 23(18):2166-2178.
30. Cesana M., Cacchiarelli D., Legnini I., et al. Along noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011 Oct 14, 147(2):358-369.